Este viernes 17 de enero, a las 11:30, nuestra compañera Marian defenderá su tesis doctoral en la Sala de Graus del edificio Antoni Maria Alcover i Sureda de la UIB. Si no podéis asistir presencialmente, este es el enlace: ddec1-0-en-ctp.trendmicro.com/wis/clicktime/…

Enhorabuena @mariangomis9 por la magnífica defensa. Muchas felicidades, doctora!

Enhorabona! Ha estat un plaer formar part del tribunal. Una defensa brillant!

arpbigidisba @mariangomis9 Muchas felicidades, @mariangomis9 !

Enhorabuena @mariangomis9 👏👏👏

⚡ La última revisión de Lancet sobre Gram negativas multirresistentes incorpora: ▶️ Tabla actualizada con espectro antibiótico ▶️ Infografía resumen de recomendaciones de IDSA y ESCMID para ESBL, AmpC, CRE, Pseudomonas y Acinetobacter resistentes thelancet.com/journals/lance…

Excited to announce that our last work on MPCs and phenotypic and genomic profiling of first-step resistance mechanisms to classical and novel β-lactams in Pseudomonas aeruginosa is out!! ⁦Antonio Oliver⁩ ⁦@mariangomis9⁩ ⁦arpbigidisba⁩ ⁦ journals.asm.org/doi/10.1128/aa…

Tomorrow March 14th last chance to apply for a grant to participate in the #ESGARS ESCMID JPIAMR 2nd hands on WS on P. aeruginosa resitance phenotypes and genomics in Mallorca, Spain arpbigidisba Microbiología Clínica HUSE IdISBa HU Son Espases CIBERINFEC @GEMARA_SEIMC

Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa - Clinical Microbiology and Infection clinicalmicrobiologyandinfection.com/article/S1198-… @mariangomis9 Jorge Arca Suárez Microbiología Clínica HUSE arpbigidisba IdISBa HU Son Espases @ci

Ceftazidime-avibactam (a last resort drug) use selects multidrug-resistance and prevents designing collateral sensitivity (CS) based therapies against P. aeruginosa (no robust patterns of CS emerge). Happy to see it published! 🥳 Centro Nacional de Biotecnología (CSIC) Microbiología Clínica HUSE nature.com/articles/s4146…

This, together with the impossibility of using previously described CS-based strategies, supports that avibactam should be restricted to limited infection cases. Great collaboration with Antonio Oliver & @mariangomis9 🤩Microbiología Clínica HUSE @ciberinfec Centro Nacional de Biotecnología (CSIC)

Nou article a #Docusalut: 💊🦠 Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus... hdl.handle.net/20.500.13003/2… Microbiología Clínica HUSE Carla López-Causapé Antonio Oliver arpbigidisba IdISBa #PublicaSalutIB

Hem publicat un nou article a la revista Biofilm! ***** ¡Hemos publicado un nuevo artículo en la revista Biofilm! ***** We’ve published a new article in Biofilm! IdISBa Microbiología Clínica HUSE HU Son Espases sciencedirect.com/science/articl…

Hem publicat un nou article! Hemos publicado un nuevo articulo! We’ve published a new article! Antimicrobial Agents and Chemotherapy journals.asm.org/doi/10.1128/aa… IdISBa Microbiología Clínica HUSE HU Son Espases

Demà divendres 20 de juny, a les 12.00 hores, la nostra companya Isabel Maria Barceló Munar, defensarà la seva tesi doctoral a la Sala de Graus, edifici Gaspar Melchor de Jovellanos, UIB Enllaç d'emissió en directe: postgrau.uib.es/doctorado_defe…

The “2nd Hands On Workshop on Pseudomonas aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis” will begin in 2 months. This ESCMID workshop is organized by members of our group and will take place at the facilities of the Son Espases University Hospital.

#PublicaSalutIB Microbiología Clínica HUSE i IdISBa  ha participat en la publicació d'un estudi sobre l'ús de la ceftazidima-avibactam indueix multiresistència i limita teràpies col·laterals contra P. aeruginosa infosalut.com/investigacio/e… doi.org/10.1038/s41467… Antonio Oliver @sonespases

🚨 Just published: the largest Spanish survey on Pseudomonas aeruginosa resistance to cefiderocol (1735 isolates, 66 hospitals) 🦠 Only 0.29% were resistant, good activity against XDR/DTR strains 🧬 Analysis of genomic resistance drivers, including novel players like PiuE

Getting ready for the 2nd Ed of our WS of Pseudomonas aeruginosa antibiotic resistance #ESGARS ESCMID JPIAMR @microhuse IdISBa arpbigidisba HU Son Espases @ciberinfec Universitat de les Illes Balears - UIB Looking forward to lab work with 20 brilliant students and top talks by world field leaders

It’s been a pleasure to attend the talk given by Dr. Craig Maclean on chromosomal capture of beneficial genes, based on his work: academic.oup.com/ismej/article/…, held at the Department of Biology, University of Oxford.